» Articles » PMID: 25595186

WWOX, the Chromosomal Fragile Site FRA16D Spanning Gene: Its Role in Metabolism and Contribution to Cancer

Overview
Specialty Biology
Date 2015 Jan 18
PMID 25595186
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The WWOX gene spans the common chromosomal fragile site FRA16D that is located within a massive (780 kb) intron. The WWOX gene is very long, at 1.1 Mb, which may contribute to the very low abundance of the full-length 1.4 kb mRNA. Alternative splicing also accounts for a variety of aberrant transcripts, most of which are devoid of C-terminal sequences required for WWOX to act as an oxidoreductase. The mouse WWOX gene also spans a chromosomal fragile site implying some sort of functional relationship that confers a selective advantage. The encoded protein domains of WWOX are conserved through evolution (between humans and Drosophila melanogaster) and include WW domains, an NAD -binding site, short-chain dehydrogenase/reductase enzyme and nuclear compartmentalization signals. This homology has enabled functional analyses in D. melanogaster that demonstrate roles for WWOX in reactive oxygen species regulation and metabolism. Indeed the human WWOX gene is also responsive to altered metabolism. Cancer cells typically exhibit altered metabolism (Warburg effect). Many cancers exhibit FRA16D DNA instability that results in aberrant WWOX expression and is associated with poor prognosis for these cancers. It is therefore thought that aberrant WWOX expression contributes to the altered metabolism in cancer. In addition, others have found that a specific (low-expression) allele of WWOX genotype contributes to cancer predisposition.

Citing Articles

DNA polymerase zeta can efficiently replicate structures formed by AT/TA repeat sequences and prevent their deletion.

Das M, Hile S, Brewster J, Boer J, Bezalel-Buch R, Guo Q Nucleic Acids Res. 2024; 53(3).

PMID: 39727171 PMC: 11797062. DOI: 10.1093/nar/gkae1254.


Multi-Omics Analysis of NCI-60 Cell Line Data Reveals Novel Metabolic Processes Linked with Resistance to Alkylating Anti-Cancer Agents.

Rushing B Int J Mol Sci. 2023; 24(17).

PMID: 37686047 PMC: 10487847. DOI: 10.3390/ijms241713242.


Wwox Binding to the Murine Brca1-BRCT Domain Regulates Timing of Brip1 and CtIP Phospho-Protein Interactions with This Domain at DNA Double-Strand Breaks, and Repair Pathway Choice.

Park D, Gharghabi M, Reczek C, Plow R, Yungvirt C, Aldaz C Int J Mol Sci. 2022; 23(7).

PMID: 35409089 PMC: 8999063. DOI: 10.3390/ijms23073729.


WWOX-Related Neurodevelopmental Disorders: Models and Future Perspectives.

Steinberg D, Aqeilan R Cells. 2021; 10(11).

PMID: 34831305 PMC: 8623516. DOI: 10.3390/cells10113082.


Neonatal neuronal WWOX gene therapy rescues Wwox null phenotypes.

Repudi S, Kustanovich I, Abu-Swai S, Stern S, Aqeilan R EMBO Mol Med. 2021; 13(12):e14599.

PMID: 34747138 PMC: 8649866. DOI: 10.15252/emmm.202114599.


References
1.
Abdel-Salam G, Thoenes M, Afifi H, Korber F, Swan D, Bolz H . The supposed tumor suppressor gene WWOX is mutated in an early lethal microcephaly syndrome with epilepsy, growth retardation and retinal degeneration. Orphanet J Rare Dis. 2014; 9:12. PMC: 3918143. DOI: 10.1186/1750-1172-9-12. View

2.
Bednarek A, Laflin K, Daniel R, Liao Q, Hawkins K, Aldaz C . WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res. 2000; 60(8):2140-5. View

3.
Glover T, Arlt M, Casper A, Durkin S . Mechanisms of common fragile site instability. Hum Mol Genet. 2005; 14 Spec No. 2:R197-205. DOI: 10.1093/hmg/ddi265. View

4.
Aqeilan R, Donati V, Gaudio E, Nicoloso M, Sundvall M, Korhonen A . Association of Wwox with ErbB4 in breast cancer. Cancer Res. 2007; 67(19):9330-6. DOI: 10.1158/0008-5472.CAN-07-2147. View

5.
Aqeilan R, Donati V, Palamarchuk A, Trapasso F, Kaou M, Pekarsky Y . WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function. Cancer Res. 2005; 65(15):6764-72. DOI: 10.1158/0008-5472.CAN-05-1150. View